|
|
|
|
MicroPulse P3® Delivery Device Versatile and Non-Incisional Glaucoma Treatment With MicroPulse® Transscleral Laser Therapy - A success rate of 60% to 80%1-17
- Achieves IOP reduction of 30% to 45%1, 3, 6, 9-15, 17, 18
- Durability of up to 72 months with 3 retreatments19
- Over 120,000 patients treated in 60 countries
- Leaves future treatment options open
Other Glaucoma Products Download MicroPulse P3 Product Brochure Download The Retina Portfolio Brochure
|
Schedule a hands-on demo Schedule a no-obligation demo to see for yourself how MicroPulse Technology and IRIDEX’s Family of Products can take YOUR practice to the next level.
|
|
Re-Thinking Glaucoma Care MICROPULSE® TRANSSCLERAL LASER THERAPY (TLT)
A cost-effective combination of safety, efficacy, durability and repeatability in a non-incisional approach to glaucoma care. MicroPulse Transscleral Laser Therapy via the MicroPulse P3® Device offers you and your patients a therapy which can be introduced prior to, in conjunction with and following all other available glaucoma treatment options, and the ability to treat at several different time points throughout the course of the disease. - A success rate of 60% to 80%1-17
- Leaves future treatment options open
- Achieves IOP reduction of 30% to 45%1, 3, 6, 9-15, 17, 18
- Durability of up to 72 months with 3 retreatments19
- Used in 38 of the 39 best hospitals in the United States*
- Reduction in drug burden in eye drops and oral medications1-4, 6-13, 18
- Revised probe now available with improved ease of use, visualization, fit, and coupling
- Limited amount of immediate follow-up
- Patient downtime is significantly low
- Low investment for high utility
- Economic savings to patients
- Covered under CPT 66710 in the U.S.A.**
1 Zaarour K, et al. J Glaucoma 2019. 2 Subramaniam K, et al. Cornea 2019. 3 Nguyen AT, et al. Eur J Ophthalmol 2019. 4 Barac R, et a. Romanian J Ophthalmol 2018. 5 Sanchez FG, et al. Arch Soc Esp Oftalmol 2018. 6 Lee JH, et al. J Glaucoma 2017. 7 Sarrafpour S, et al. Ophthalmology Glaucoma 2019. 8 Awoyesuku EA, et al. JAMMR 2019. 9 Abdelrahman AM, et al. J Glaucoma 2018. 10 Aquino MC, et al. Clin Exp Ophthalmol 2015. 11 Jammal AA, et al. Arq Bras Oftalmol 2019. 12 Tan A, et al. Clin Experiment Ophthalmol 2010. 13 Williams AL, et al. J Glaucoma 2018. 14 Varikuti VNV, et al. J Glaucoma 2019. 15 Souissi S, et al. Eur J Ophthalmol 2019. 16 Magacho L, et al. Lasers Med Sci 2019. 17 Magacho L, et al. J Glaucoma 2019. 18 Yelenskiy A, et al. J Glaucoma 2018. 19 Aquino M, et al. European Glaucoma Society 2016. * As ranked by U.S. News and World Report. ** National reimbursement for CPT code 66710 in the United States is as follows: $453 for physician payment in physician office, $400 for physician payment in ASC, $836 for facility payment in ASC, $400 for physician payment in hospital outpatient department, and $1,934 for facility payment in hospital outpatient department.
SURGICAL GUIDE Surgical Guide for MicroPulse® Transscleral Laser Therapy using the MicroPulse P3® Delivery Device - A viscous, liquid interface (e.g. methyl cellulose) must be utilized to ensure proper light coupling to the conjunctiva. Place a drop on the undersurface of the probe footplate. Reapply as necessary. Not using a liquid interface could result in an inconsistant application of laser energy.
- Orient the probe with the wide, curved side (bunny ears) aligned at the surgical limbus to ensure consistent treatment application. Be sure to view from directly above to avoid placement error because of parallax.
- Maintain the entirety of the probe footplate flat against the conjunctiva throughout the treatment while applying constant and gentle pressure (Figure 1). Do not rock the probe while sweeping.
- Treat one hemisphere or quadrant of the eye at a time. Sweep the MicroPulse P3 Probe along the limbus in an arc of 75 degrees per quadrant (Figure 2) or 150 degrees per hemisphere (Figure 3) for between 10 - 20 seconds. Reverse the direction and repeat for a total of 3-5 passes. Avoid the 3 and 9 o’clock meridians.
- Average laser powers of 2000mW - 2500mW at a duty cycle of 31.3% have been reported safe and effective by physicians in published scientific literature.1, 2
Technique Instructions - Apply a liquid viscous interface to the bottom of the delivery device footplate and/or the eye to be treated. This is a mandatory requirement.
- Orient the probe with the wide, curved side (bunny ears) aligned at the surgical limbus to ensure consistent treatment application. Holding the delivery device with the tips of your fingers allows you to rotate the probe as you sweep to keep the orientation aligned with the limbus throughout the procedure.
- Keep the scleral-matching curvature flat and flush with the sclera throughout the procedure. It is important that you do not rock probe and keep full contact throughout the procedure.
- Remember to avoid the 3 and 9 o’clock positions when treating.
- The tapered stem can be used as your speculum if need be in very tight orbits.
- Treat one hemisphere or quadrant of the eye at a time. Sweep the MicroPulse P3 Probe along the limbus in an arc of 75 degrees per quadrant (Figure 2) or 150 degrees per hemisphere (Figure 3) for between 10 - 20 seconds. Reverse the direction and repeat for a total of 3-5 passes. Avoid the 3 and 9 o’clock meridians.
- Average laser powers of 2000mW - 2500mW at a duty cycle of 31.3% have been reported safe and effective by physicians in published scientific literature.1, 2
- Standard post-operative medication regimen is steroid drops QID x 1 week and then BID x 1 week. Cycloplegia is not required following MicroPulse TLT.
- Nguyen AT, Maslin J, Noecker RJ. Early results of micropulse transscleral cyclophotocoagulation for the treatment of glaucoma. Eur J Ophthalmol. 2020;30(4):700-705.
- Kaba Q, Somani S, Tam E, Yuen D. The effectiveness and safety of micropulse cyclophotocoagulation in the treatment of ocular hypertension and glaucoma. OphthalmolGlaucoma. 2020;3(3):181-189.
WEBINARS
Glaucoma MicroPulse Transscleral Laser Therapy before incisional procedures Panelists Michael Giovingo, MD; Mona Kaleem, MD Ahad Mahootchi, MD Watch On-Demand Glaucoma MicroPulse Transscleral Laser Therapy in combination with other glaucoma treatments Panelists Courtney Bovee, MD; Rajen U. Desai, MD, FACS Sebastian B. Heersink, MD Watch On-Demand Glaucoma MicroPulse Transscleral Laser Therapy after incisional glaucoma treatments Panelists Jella An, MD; Analisa Arosemena, MD Jacob Brubaker, MD; Shan Lin, MD Watch Webinar When to treat glaucoma with MicroPulse TLT and when to treat with CWTSCPC Panelists Mahmoud A. Khaimi, MD; Richard K. Lee, MD, PhD Robert Noecker, MD, MBA; Nir Shoham-Hazon, MD Thursday, May 20 @ 5:00pm (California Time) Register Traitement du glaucome non incisionnel et améliorations apportées à la conception de la sonde MicroPulse P3 Panéliste Professeur Philippe Denis; Professeur Florent Aptel; Professeur Max Villain Available On-Demand All-Laser Approach to Glaucoma Panelists Ike K. Ahmed, MD; Jella An, MD; Mahmoud A. Khaimi, MD Available On-Demand The Evolution and Versatility of MicroPulse® TLT for Glaucoma: Experiences in Asia Pacific Panelists Prof. Makoto Aihara, MD; Ilesh Patel, MD; Maria Cecilia Aquino, MD; Victor Koh, MD; Jacky Lee, MD Available On-Demand The Evolution and Versatility of MicroPulse® TLT for Glaucoma: Experiences in Europe Panelists Prof. Florent Aptel, MD, PhD; Ronald De Crom, MD; Marc Mackert, MD, FEBO; Marc Töteberg-Harms, MD, FEBO Available On-Demand The Evolution and Versatility of MicroPulse® TLT for Glaucoma: Experiences in India, US, and UK Panelists Sathyan Parthasarathy, MD; Alka Pandey, MD; Sonal G. Chhaya, MD; Syril Dorairaj, MD; Prof. Philip Bloom, MD Available On-Demand The Evolution and Versatility of MicroPulse® TLT for Glaucoma: Experiences in the Middle East and North Africa Panelists Ziad Khoueir, MD; Ahmed Al Habash, MD; Ahmad Abdel Meguid, MD, PhD, FRCS EDIN Ohood Owaidhah, MD; Walid Zbiba, MD Available On-Demand La Evolución y Versatilidad de la Terapia MicroPulse Para Glaucoma: Experiencias en Latinoamérica (Primera Parte) Panelistas Tomás M. Grippo, MD; Vanessa Liberato, MD; Vital P. Costa, MD; Francisco Ortega, MD; María F. Delgado, MD Ver Webinar La Evolución y Versatilidad de la Terapia MicroPulse Para Glaucoma: Experiencias en Latinoamérica (Segunda Parte) Panelistas Fabián Lerner, MD; Jesús Jiménez Román, MD; Yini Datt, MD; Curt Hartleben, MD; Tomás M. Grippo, MD; Gustavo Avilés, MD Ver Webinar The revised MicroPulse P3® Device: What You Need to Know Speaker Michael Giovingo, MD Available On-Demand How I Am Treating Glaucoma During the COVID-19 Pandemic Speaker Jason Bacharach, MD Watch Webinar My Experience with MicroPulse® Transscleral Laser Therapy for Glaucoma Speaker Rajen Desai, MD Watch Webinar Utilizing MicroPulse® Transscleral Laser Therapy in and outside my glaucoma practice Speaker Brian Francis, MD, MS Watch Webinar Optimizing MicroPulse® Transscleral Laser Therapy for Multiple Glaucoma Types Speaker Nathan Radcliffe, MD Watch Webinar The Role of MicroPulse® Transscleral Laser Therapy for Glaucoma Speaker Brian Jerkins, MD Watch Webinar
STUDIES
|
The Effectiveness and Safety of Micropulse Cyclophotocoagulation in the Treatment of Ocular Hypertension and Glaucoma
Qayim Kaba • Sohel Somani, MD • Eric Tam, MD • Darana Yuen, MD
Ophthalmology Glaucoma • 2020 • Learn More
|
|
Micropulse Transscleral Diode Laser Cyclophotocoagulation in Refractory Glaucoma
American Academy of Ophthalmology
2020
Download Now
|
|
Venkata Varikuti: Outcomes of MicroPulse Transscleral Cyclophotocoagulation in Eyes With Good Central Vision
Journal of Glaucoma
2019
Download Now
|
|
Zaid Khoueir: Outcomes of Micropulse Transscleral Cyclophotocoagulation in Uncontrolled Glaucoma Patients
Glaucoma Journal
March 2019
Download Now
|
|
Vital Costa: Prospective evaluation of mTSCPC in refractory glaucoma 1 yr results
Arquivos Brasileiros de Oftalmologia
2019
Download Now
|
|
Aleksandr Yelenskiy: Patient Outcomes Following MicroPulse Transscleral Cyclophotocoagulation: Intermediate-term Results
Glaucoma Journal
October 2018
Download Now
|
|
Ahmed M. Abdelrahman: Micropulse Versus Continuous Wave Transscleral Cyclophotocoagulation in Glaucoma Journal
October 2018
Download Now
|
|
Alice Williams: Clinical Efficacy and Safety Profile of Micropulse Transscleral Cyclophotocoagulation in Refractory Glaucoma
Glaucoma Journal
May 2018
Download Now
|
|
Ramona Barac: Choroidal thickness increase after micropulse transscleral cyclophotocoagulation
Romanian Joournal of Opthalmology
April 2018
Download Now
|
|
Jun Hui Lee: Outcome of Micropulse Laser Transscleral Cyclophotocoagulation on Pediatric Versus Adult Glaucoma Patients
Glaucoma Journal
October 2017
Download Now
|
|
Matthew Emanuel: Micropulse Cyclophotocoagulation: Initial Results in Refractory Glaucoma
Glaucoma Journal
August 2017
Download Now
|
|
Edward Bendel: mTSCPC Observational Report
2017
Download Now
|
|
Maria Cecilia Aquino: Long-term Efficacy of Micropulse Diode Transscleral Cyclophotocoagulation in the Treatment of Refractory Glaucoma
National University Health System
2017
Download Now
|
|
Rolando Toyos: Clinical Outcomes of Micropulsed Transcleral Cyclophotocoagulation in Moderate to Severe Glaucoma
Journal of Clinical & Experimental
Opthalmology 2016
Download Now
|
|
Sarah Kuchar: Treatment outcomes of micropulse transscleral cyclophotocoagulation in advanced glaucoma
Springer-Veriag London
December 2015
Download Now
|
|
Maria Cecilia Aquino: Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma: a randomized exploratory study
Clinical & Experimental
Opthalmology 2014
Download Now
|
|
Anna Tan: Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma
Clinical & Experimental
Opthalmology 2010
Download Now
|
|
Antonio Maria Fea: MicroPulse diode laser trabeculoplasty (MDLT): A phase II clinical study with 12 months follow-up
Clinical Ophthalmology
2008
Download Now
|
|
MicroPulse P3: Peer Reviewed Studies Summary
Download Now
|
ARTICLES MicroPulse Transscleral Laser Therapy After Tube Shunt Surgery April 2020 - Glaucoma Today By Brian M. Jerkins, MD 2019
Outcome of MicroPulse Transscleral Photocoagulation in different Types of Glaucoma December 2019 - Clinical Ophthalmology By Ahmed Al Habash, MD Micropulse Transscleral Diode Laser Photocoagulation: What We Do and Don't Know December 2019 - Medscape By Shuchi B. Patel, MD MicroPulse Trans-scleral Laser Therapy for Glaucoma December 2019 - Glaucoma Physician By Vital Costa, MD Outcomes of MicroPulse Transscleral Cyclophotocoagulation in Eyes With Good Central Vision October 2019 - Journal of Glaucoma By Venkata Varikuti, MD MicroPulse cyclophotocoagulation effective in keratoplasty eyes August 2019 – EyeWorld By Robert Noecker, MD Cook County Health presents glaucoma studies at ARVO May 2019 – Ocular Surgery News By Michael C. Giovingo, MD Study shows MicroPulse laser controls IOP after keratoplasty May 2019 – Ocular Surgery News By Jessica Minjy Kang, MD Avoiding issues from inflow procedures May 2019 – Ophthalmology Times By Jeffrey Kammer, MD Subthreshold laser shows favorable foveal remodeling after macular hole closure May 2019 – Ocular Surgery News By Boris Stanzel, MD Standardizing techniques for MicroPulse cyclophotocoagulation needed April 2019 - Healio Ocular Surgery News By Jella An, MD Outcomes of Micropulse Transscleral Cyclophotocoagulation in Uncontrolled Glaucoma Patients March 2019 – Glaucoma Journal By Ziad Khoueir, MD Transscleral MicroPulse CPC in Open-Angle Glaucoma February 2019 – Glaucoma Today By Fahad Khan, MD; and Rohit Krishna, MD The role of MicroPulse therapy February 2019 – Ophthalmology Management By Ahad Mahootchi, MD Which MIGS for which patient? January 2019 – Ophthalmology Times By Brian A. Francis, MD, MS 2018 Micropulse Transscleral Cyclophotocoagulation: A Hypothesis for the Ideal Parameters November 2018 - Medical Hypothesis, Discovery &Innovation Ophthalmology Journal By Tomas M. Grippo, MD Try this laser before you go to the OR October 2018 - Ocular Surgery News By Melissa Toyos, MD Video: MicroPulse for mild to moderate stage glaucoma August 2018 - Ocular Surgery News By Sandra Fernando-Sieminski, MD MicroPulse not just for end-stage glaucoma patients August 2018 - Ocular Surgery News By Sandra Fernando-Sieminski, MD Reassessing TSCPC’s role August 2018 - The Ophthalmologist By David Gossage, DO Micropulse P3™ (MP3) Laser for Glaucoma: An Innovative Therapy August 2018 – JOCGP By Maria Cecilia Aquino, MD Efficacy and safety of Micropulse® transscleral cyclophotocoagulation in glaucoma August 2018 – Archivos Espanola By F.G. Sancheza, MD MicroPulse stimulates cells May 2018 - Ocular Surgery News By Melissa Toyos, MD Micropulse cyclophotocoagulation minimizes post-treatment sequelae May 2018 - Ocular Surgery News By Soshian Sarrafpour, MD MicroPulse cyclophotocoagulation — the ultimate in flexibility March 2018 - Ocular Surgery News By Melissa Toyos, MD MicroPulse technology reduces IOP in wide range of glaucomatous eyes February 16, 2018 - Ocular Surgery News By Shan Lin, MD 2019 Applying micropulse transscleral cyclophotocoagulation for early-stage glaucoma November 2017 - Ophthalmology Times By Robert J. Noecker, MD MicroPulse technology allows safe treatment of glaucoma November 2017 - Ocular Surgery News By David Gossage, DO Video: Micropulse cyclophotocoagulation a safe alternative to incisional glaucoma procedures October 2017 - Ocular Surgery News By Marc Toeteberg-Harms, MD New Laser Therapies for Glaucoma September 2017 - Cataract & Refractive Surgery Today By Nisha Chadha, MD
VIDEOS | | Iridex Academy: A Primer on MicroPulse Transscleral Laser Therapy for Glaucoma - Brian Francis, MD | | | MicroPulse TLT: Improving Outcomes and Patient Experience - Michael C. Giovingo, MD | | | MicroPulse TLT: When MIGS Fails...Non-incisional IOP Control for Glaucoma - Robert J. Noecker, MD | | | MicroPulse TLT: An Efficient and Effective Glaucoma Treatment - Nathan M. Radcliffe, MD | | | MicroPulse TLT: Your Reliable, Repeatable, & “Patient Friendly” IOP Reduction Option - Elaine Ye Wang, MD | | | Iridex New Sweep Management Software for MicroPulse TLT | | | MicroPulse transscleral laser therapy aims to increase outflow to reduce IOP – Ye Elaine Wang, MD | | | Add MicroPulse TLT to Your Glaucoma Toolkit - Ye Elaine Wang, MD | | | MicroPulse TLT for Glaucoma Management in a Comprehensive Practice - Shahed Y Ghoghawala, MD | | | The Best Part of MicroPulse TLT in a Tertiary Practice - Larissa Camejo, MD | | | Advantages of MicroPulse P3 Cyclophotocoagulation | | | Treating Glaucoma with the Cyclo G6 Laser - Long-Term Results | | | Webinar with Dr. Nathan Radcliffe: Optimizing MicroPulse TSCPC for Multiple Glaucoma Types | | | Webinar with Dr. Brian Jerkins: The Role of MicroPulse TSCPC for Glaucoma | | | Dr. Takashi Fujishiro, MD talks about MicroPulse® TSCPC by Cyclo G6 | | | Dr. Nathan Radcliffe Discusses Experience with Cyclo G6 Laser | | | Testimonial Dr Vital Paulino Costa Spanish | | | Treating Glaucoma With MicroPulse Laser Therapy | | | MicroPulse P3 Procedure for Glaucoma: Beyond Late Stage | | | MicroPulse CPC Glaucoma Treatment and Patient’s Profiles | | | Updates from the MicroPulse Aqueous Dynamics Study in Early or Moderate POAG | | | IRIDEX MicroPulse ESCRS 2018 Symposium Q&A | | | IRIDEX at the American Academy of Ophthalmology 2018 | | | Treating Glaucoma with the Cyclo G6 Laser - Long-Term Results | | | Glaucoma Laser Treatment Now Available in Russia - Cyclo G6 Glaucoma Laser | | | Cyclo G6™ Glaucoma Laser, an Alternative to Stents for Glaucoma - Dr. Rolando Toyos | | | Laser-Assisted, Non-incisional Glaucoma Therapy | | | Glaucoma Treatment With MicroPulse Therapy The award-winning series, Innovations with Ed Begley Jr., featured IRIDEX MicroPulse therapy for glaucoma on CNBC. In this episode, three top glaucoma specialists share what it is and how it works, and three glaucoma patients share how MicroPulse therapy has helped them to control glaucoma. | | | Effect of Transscleral Diode Cyclophotocoagulation AGS The effect of Transscleral Diode Cyclophotocoagulation using MicroPulse versus Continuous Wave on Ciliary Body observed in Miyaki Apple View. John A. Moran Eye Center University of Utah. Do you ever wonder what CPC looks like inside the eye? | | | IRIDEX AAO Dr Sieminski Dr. Sandra Sieminski talks about MicroPulse ® Technology for Glaucoma. Listen along as Dr. Sieminski shares results from a 6 month study on patients treated with the Cyclo G6 ™ Glaucoma Laser System. | | | EGS Symposium: MicroPulse Therapy for Glaucoma Treatment Dr. Ziad Khoueir (Lebanon), Dr. Ronald de Crom (The Netherlands), Dr. Marc Toeteberg (Switzerland), and Dr. Karin Roswitha Pillunat (Germany) share how they are successfully treating multiple cases of glaucoma with the Cyclo G6 Glaucoma Laser and MicroPulse Technology at the European Glaucoma Society (EGS) congress in Florence, Italy. | | | Latest Data on MicroPulse Cyclophotocoagulation In this interview from AGS 2017, Dr. Jonathan Myers discusses MicroPulse. At the meeting, the 10 posters on the MicroPulse showed good pressure reduction and success rates ranging from 50% to 80%. | | | Cyclophotocoagulation with the CYCLO G6 laser EyeWorld Interviews Dr. Shan Lin at AAO about his experience treating glaucoma with the CYCLO G6 Glaucoma Laser. | | | CYCLO G6 laser for Glaucoma Dr. Nathan Radcliffe talks with EyeWorld at AAO about how MicroPulse works and how and why he treats glaucoma with the CYCLO G6 Glaucoma Laser. | | | Symposium: IRIDEX MicroPulse® Technology Revolutionizes Cyclophotocoagulation In this symposium from ESCRS 2017, MicroPulse experts (Drs. Ziad Khoueir, Robert Noecker, and Marc Töteberg-Harms) discuss their experience using IRIDEX lasers and MicroPulse Technology to treat glaucoma. | | | CYCLO G6 laser featured in the news WTCO Local News from Savannah, GA talked to Dr. Harris about treating glaucoma with MicroPulse Laser Trabeculoplasty and MicroPulse Cyclophotocoagulation. | | | MicroPulse probe transforms transscleral cyclophotocoagulation Dr. Randy Craven tells Ophthalmology Times that MicroPulse via the CYCLO G6 Laser is demonstrating promising efficacy with better safety and tolerability than traditional TSCPC. | | | Personalized Glaucoma Laser Therapy with the Titratable MicroPulse P3 Nathan Radcliffe, MD, discusses the advantages of using the MicroPulse P3 (MP3) Glaucoma Device, plus the additional benefits of providing customized cyclophotocoagulation therapy for glaucoma patients. | | | Transcleral MicroPulse Laser Dynamically Alters Ciliary Muscle and Aqueous Outflow Pathways 2017 This video by Dr. Murray Johnstone provides visually controlled, real time observation of the effects of a transcleral MicroPulse 810 nm laser. The laser pulses induce shortening of the longitudinal portion of the ciliary muscle. | | | Evolution in glaucoma surgery mounting with MIGS procedures An expanding armamentarium of minimally invasive and micro-invasive glaucoma surgery (MIGS) procedures, like laser treatment with the CYCLO G6 Glaucoma Laser, are transforming glaucoma management, said Steven D. Vold, MD. | | | Tratamiento para glaucoma con el laser IRIDEX Cyclo G6 El Dr. Marco Antonio Beltrán, especialista en glaucoma del Centro Oftalmológico de Sonora, en Hermosillo, Mexico, habla sobre el tratamiento para el glaucoma con el láser IRIDEX Cyclo G6 con MicroPulso - una alternativa para medicamentos y cirugías. | | MicroPulse, a New Procedure Arises to Help Fight Glaucoma | | Dr. Shan Lin explains how he treats glaucoma with MicroPulse therapy |
ABSTRACTS
| Selective Laser Trabeculoplasty vs Micropulse Laser Trabeculoplasty in Open-Angle Glaucoma Download Now | | Histologic Changes Following Continuous Wave And Micropulse Transscleral Cyclophotocoagulation: A Randomized Comparative Study AGS 2019 Download Now | | Transcleral Micropulse Laser (TML) Effects On Outflow System, Sclera, Ciliary Muscle (CB) & Suprachoroidal Space (SCS): Insights From High-Resolution OCT (HROCT), Real-Time Video (RTV) & Histology AGS 2019 Download Now | | Dan Yoon: Two Meta-analyses on the Outcomes of Sequential Glaucoma Drainage Implantation vs. Cyclophotocoagulation AGS 2019 Download Now | | Nadiya Kots-Gotlib: Outcomes of Ahmed Valve Implantation Supplemented with Limited Diode Cyclophotocoagulation AGS 2019 Download Now | | Beatriz Aguando: TRANSSCLERAL CYCLOPHOTOCOAGULATION WITH DIODE LASER FORREFRACTORY GLAUCOMA. OUR EXPERIENCE EGS 2018 Download Now | | Behzad Amoozgar: Comparison of Long-term Clinical Outcomes between Micropulse Transscleral Cyclophotocoagulation and Endoscopic Cyclophotocoagulation-Plus AGS 2018 Download Now | | Brett Breshears: Two-Year Retroactive Study of G6 Transscleral Cyclophotocoagulation as a Secondary Poag Treatment ASCRS 2018 Download Now | | Briana Gapsis: Analysis of the Relative Efficacy of Micropulse Laser Trabeculoplasty and Selective Laser Trabeculoplasty ARVO 2018 Download Now | | Carisa Bohnak: Micropulse Transscleral Cyclophotocoagulation in the Treatment of Patients with Primarily Severe Stage Glaucoma ASCRS April 2018 Download Now | | Catherina Goenadi: EARLY OUTCOMES OF MICROPULSE DIODE TRANSSCLERAL CYCLOPHOTOTHERAPY FOR TREATMENT OF MILD TO MODERATE GLAUCOMA EGS May 2018 Download Now | | Catherine Sun: Comparison of Outcomes of Micropulse Laser Trabeculoplasty versus Selective Laser Trabeculoplasty ARVO 2018 Download Now | | Christine Nguyen: Efficacy and Safety of Micropulse Transscleral Diode Laser Cyclophotocoagulation in the Treatment of Refractory Glaucoma ASCRS 2018 Download Now | | Cigdem Altan: EARLY CLINICAL OUTCOMES OF MICROPULSED TRANSCLERALCYCLOPHOTOCOAGULATION IN OPEN ANGLE GLAUCOMA EGS 2018 Download Now | | Dan Nguyen: Micropulse Transscleral Cyclophotocoagulation as a Primary Intervention in Primary Open-Angle Glaucoma Patients ASCRS 2018 Download Now | | Ihab Ibrahim: No More Blades, Scars or Scares: A One Year Experience of Micropulse Trans-scleral Cyclophotocoagulation from Middle East WOC 2018 Download Now | | Kareem Moussa: Histologic changes following continuous and micropulse transscleral cyclophotocoagulation: a comparative study AGS 2018 Download Now | | Karim Ghazal: Early Result of Micro Pulse Cyclophotocoagulation in Glauacoma Cases Resistant to Medication WOC June 2018 Download Now | | Krishna Patel: Effects of Micropulse Transscleral Cyclodiode Laser on Secondary Open-Angle Glaucoma ASRCS 2018 Download Now | | Leonard Seibold: Trans-scleral Cyclophotocoagulation: A Tale of Two Probes ARVO 2018 Download Now | | Marisse Masis: Pupillary mydriasis and recovery after transscleral micropulse cyclophotocoagulation AGS 2018 Download Now | | Murray Johnstone: Transcleral laser, ciliary muscle shortening & outflow pathway reorganization ARVO June 2017 Download Now | | Nadiya Kots-Gotlib: Outcomes of Ahmed Valve Implantation Supplemented with Limited Diode Cyclophotocoagulation AGS 2019 Download Now | | Phornrak Sriphon: EFFICACY OF MICROPULSE TRANSCLERAL CYCLOPHOTOCOAGULATION IN UNCONTROLLED GLAUCOMA AT SRINAGARIND HOSPITAL,THAILAND WGC 2017 Download Now | | Robert Dionisio: MLT vs SLT in the Hispanic and African American Population for Treatment of Open-Angle Glaucoma ARVO 2018 Download Now | | Satar Baghrizabehi: MICROPULSE YELLOW LASER TRABECULOPLASTY WGC 2017 Download Now | | Shotaro Asano: IOP Reduction and Morphological Changes of Ciliary Body by Micropulse Transscleral Cyclophotocoagulation WOC June 2018 Download Now | | Ted Deng: MLT (Micropulse Laser Trabeculoplasty) or Not? AGS 2018 Download Now | | Walid Zbiba: MICROPULSED TRANSCLERAL CYCLOPHOTOCOAGULATION IN GLAUCOMAMANAGEMENT: THE TUNISIAN EXPERIENCE EGS 2018 Download Now |
CASE EXAMPLES
The Case of the Creeping Paracentral Visual Field Defect What are options when a patient and her family prefer to avoid surgery? April 2020 - Glaucoma Today By Austin Bell, MD; Sylvia Groth, MD; Regine Pappas, MD; and Steven R. Sarkisian Jr, MD Case Files: A Case of Iridocorneal Endothelial Syndrome Treatment after persistent high IOP March 2020 - Glaucoma Physician By Matthew Rouse, MD MicroPulse TLT: Case Example by Dr. Rajen Desai
FREQUENTLY ASKED QUESTIONS
How can I order the MicroPulse P3 Device? The MicroPulse P3 Device comes in a box of six. To place an order, speak with your local sales rep or distributor, or contact customer service at 650.962.8100 or customerservice@iridex.com. What is the CPT code? CPT code for cyclophotocoagulation is 66710 What is the shelf life of MicroPulse P3, G-Probe, and G-Probe Illuminate? 3 years Can the MicroPulse P3 Device be reused? No. The MicroPulse P3 Device is Indicated for single-use What is MicroPulse® Technology? MicroPulse technology is a tissue-sparing solution where a continuous-wave laser beam is chopped into a train of tiny, repetitive, low energy pulses separated by a brief rest period which allows tissue to cool between laser pulses.
TRAINING How to set up, initiate, program, and clean the IRIDEX Cyclo G6 Laser. How to Measure the Power Output of the IRIDEX Cyclo G6 Laser
MICROPULSE TLT DURING COVID-19
As the COVID-19 pandemic continues, our thoughts go out to those who have been impacted. Our priority at IRIDEX is to support our customers, their patients and our employees. Over the past few months, ophthalmologists from around the world have been exchanging ideas and strategies to adapt to new social distancing guidelines, infection control measures, and treatment options to best manage their patients. During this time of uncertainty, many of our customers have shared with us how MicroPulse Transscleral Laser Therapy (TLT) remains a beneficial therapy for a variety of reasons. MicroPulse TLT: - is non-incisional, safe, and effective
- can be performed in the office
- takes less than 5 minutes to performed
- entails minimal follow-up
- leaves future treatment options open
- can be applied for a wide range of glaucoma types and severity
- typically allows patients to return to normal activities within 24 hours
- uses the Cyclo-G6 laser console that can be disinfected easily
- uses a sterile, single-use, MicroPulse P3 fiber-optic delivery device
In a webinar titled “How I Am Treating Glaucoma During the COVID-19 Pandemic,” Dr. Jason Bacharach of California discussed how the current COVID-19 pandemic has changed the way clinicians treat and manage glaucoma. “Most patients presenting for urgent care usually require stronger IOP control, so I have turned to MicroPulse TLT to bridge this gap and I treat them in the office. This is a great tool for right now,” he said. In a different webinar, Dr. Rajen Desai of New Jersey said: “Patients did not feel comfortable having to come back to the office for multiple post-op visits if I proposed incisional glaucoma surgery, so I realized I needed something dependable, predictable, safer, and low risk during this time. MicroPulse is playing a particular stronghold now that patients are averse to getting things done in general. They prioritize safety above all else, and that’s where MicroPulse shines because I tell them there is a very low risk of endophthalmitis.” In a webinar about the evolution and versatility of MicroPulse TLT, Dr. Marc Toeteberg-Harms of Switzerland said: “My elderly patients were scared to be seen in the hospital. MicroPulse TLT enabled me to be able to treat in the office immediately thus avoiding a second consultation. Plus, post-op complications are low and this minimizes post-op visits. The outside of the laser machine and the footswitch are easy to clean.” Dr. Branda Alegría of Guadalajara, Mexico contacted us via instagram to share a few photos and she told us the following: “MicroPulse Transscleral Laser Therapy is my best ally during the COVID-19 pandemic when facing challenging glaucoma cases.” We are here to help you. We are thankful and honored to be supporting hundreds of ophthalmologists and patients during this dificult time. As we go forward together, please know that we value your questions, ideas and feedback. If there is something in particular that you need, please email us at glaucoma@iridex.com or contact your IRIDEX representative. Stay safe and healthy. Treating Glaucoma with MicroPulse Therapy During COVID-19 by Dr. Marc Toeteberg How I Am Treating Glaucoma During the COVID-19 Pandemic by Dr. Jason Bacharach MicroPulse TLT: an Option for Glaucoma Treatment During COVID-19 by Dr. Rajen Desai
REVIEWS "The revised MicroPulse P3 Device is intuitive and easy to use. The design delivers energy in a much more consistent fashion and allows for very stable contact on the sclera.” Brian A. Francis, MD, MS Doheny Eye Institute, UCLA
“I was using the Cyclo G6 glaucoma laser for refractory glaucoma patients, but as I saw the results and how comfortable the patients were, I started to expand its use, and now I use it for various types of glaucoma cases.” Sandra Fernando Sieminski, MD Ross Eye Institute, Buffalo, NY USA
"When treating patients with glaucoma, my number one goal is to prevent blindness and my number two goal is to prevent incisional glaucoma surgery, and MicroPulse Therapy can help me to achieve both.” Nathan Radcliffe, MDNew York Eye Surgery Center
“The technique for performing MicroPulse TLT for glaucoma was already great in the past. The minimal tissue damage is a major advantage of MicroPulse TLT over standard cyclophotocoagulation in my opinion. Iridex has done a great job improving the MicroPulse P3 Device. The ergonomic enhancements made to the design of the MicroPulse P3 Device now allows a smoother movement during treatment. I feel much more comfortable, and this is resulting in an even safer and more stable treatment for glaucoma.” Marc Toeteberg-Harms, MD, FEBO Zurich, Switzerland
“I have performed over a hundred MicroPulse TLTs, and have not experienced a single case of iritis or CME. MicroPulse TLT is safe, effective, and can be done in the office and OR in less than 5 minutes. For surgeons who may not feel comfortable adopting the newest MIGS devices but want something effective and safe to reduce IOP with the simplest learning curve, MicroPulse TLT is an outstanding option.” Rajan Desai, MD, FACS East Brunswick, NJ
“Numerous published studies and clinical experience in the US, Europe and Asia over the last several years have demonstrated that it is a safe and effective option to decrease both IOP and the number of topical medications necessary in many glaucoma patients. I regularly treat a wide variety of glaucoma patients with it, and my patients are very happy with the results.” Ahad Mahootchi, MD The Eye Clinic of Florida, Zephyrhills, FL USA
“MicroPulse TLT has become an irreplaceable tool in my daily practice. It has allowed me to better individualize the care of my glaucoma patients, minimizing risks and allowing for clinical success even in challenging scenarios where I used to have none or few and risky treatment options. It is an evolving technology, and as we continue to learn more about it, we will unveil its full potential.” Tomas M. Grippo, MD Grippo Glaucoma Center, Buenos Aires, Argentina
“Since 2016, I have loved having MicroPulse TLT in my surgical toolbox for many types of glaucoma, including those in late stage and refractory stages. I am a big fan because this can often save someone from incisional surgery. Of course, selecting the right patient is key to ensure good outcomes and minimal side effects.” Monisha Vora, MD Wills Eye Hospital
“In a study that I performed with 71 eyes of 68 patients, I found that MicroPulse TLT demonstrated good efficacy and safety profiles with minimal vision-threatening complications in treating a variety of glaucoma types.” Ahmed Al Habash, MD Imam Abdulrahman Bin Faisal University, Saudi Arabia
“The MicroPulse P3 Device has become an essential part of my armamentarium for use in glaucoma surgical procedures. It provides a very safe and efficacious solution for IOP control. I have used MicroPulse P3 for some of my most complicated cases but also I feel comfortable enough using it for patients with earlier disease in which we want to avoid a filtering bleb or the placement of hardware in the eye.” Robert Noecker, MD, MBA Ophthalmic Consultants of Connecticut, Fairfield, CT USA
“MicroPulso laser therapy helps our patients by significantly reducing intraocular pressure without the need for invasive surgeries. We are very happy with the results.” Vanessa Liberato, MD Santo Domingo, Republica Dominicana
“I have been using MicroPulse TLT in my practice for more than 2 years. MicroPulse mode has proven to be an efficacious choice for many of my glaucoma patients, with significant reduction in pressure and medication use for most. I have found that after MicroPulse TLT procedures, my patients experience less pain and less post-procedural inflammation than after traditional CPC.” Jonathan S. Myers, MD Wills Eye Hospital
“The MicroPulse P3 Device has given me over 30% IOP lowering. With patients that are non-compliant with their medication, or we are really trying to keep off their medication, the MicroPulse P3 device allows me to treat patients more aggressively.” Steven Vold, MD Vold Vision, Fayetteville, AR USA
“MicroPulse Transscleral Laser Therapy is my best ally during the COVID-19 pandemic when facing challenging glaucoma cases. I have been using MicroPulse TLT with the Cyclo G6 Laser to treat glaucoma for nearly two years and my outcomes have been excellent so far.” Branda Alegría, MD Guadalajara, Mexico
“I have been impressed that the MicroPulse therapy can deliver pressure lowering in a broad range of glaucomas, including mild and moderate patients who I want to free from the adverse effects of drops.” Rolando Toyos, MD Toyos Clinic, Nashville, TN USA
“I have found the MicroPulse P3 Device to be a non-incisional, easy, and safe way to reduce pressure anytime my patients need it, and it is predictable and highly efficacious.” Melissa Toyos, MD Toyos Clinic, Nashville, TN USA
“Today we treated 8 patients, and we saw considerable reductions in IOP in all of them. Plus, we avoided the need for a valve in two of the patients.” Gustavo Aviles, MD, PhD Lima, Peru
“In my practice, the addition of MicroPulse TLT has proven to be a safe, effective and reliable approach for lowering IOP. Personally, I have used MicroPulse TLT on patients with mild to wild glaucoma – and for good reason. It is safe and effective without yielding major impact on the target tissue, and it’s repeatable if necessary.” Nir Shoham-Hazon, MD Miramichi, Canada
“I have been using MicroPulse TLT to treat glaucoma for the past few months. The outcomes have been positive. I particularly use it in patients with cataract and glaucoma to reduce or eliminate their dependency on medications.” José Antonio Bermudez Magner, MD Mexico City, Mexico
“MicroPulse TLT shows promise for surgeons who wish to avoid further invasive procedures. It also works well in tandem with tube shunt implants before primary implantation. Overall, the procedure is straightforward and fast, with easy recovery and minimal complication rates.” Brian M. Jerkins, MD Hamilton Eye Institute, Memphis, TN USA
“It is important to have many choices in managing chronic diseases like glaucoma. Because MicroPulse laser is non-incisional and repeatable, it keeps all other options open.” Makoto Aihara MD, PhD University of Tokyo, Japan
“MicroPulse P3 is very effective in the treatment of late stage glaucoma. Early clinical data suggest it may also be an effective treatment to reduce IOP in mild to moderate glaucoma.” Maria Cecilia Aquino, MD National University Hospital Singapore
“MicroPulse P3 for glaucoma has improved my ability to treat more patients with a repeatable procedure.” Poemen Chan, MD The Chinese University of Hong Kong
REIMBURSEMENT
MONOGRAPH A monograph was recently developed by Corcoran Consulting Group addressing the reimbursement issues associated with MicroPulse® transscleral laser therapy (also known as MicroPulse transscleral cyclophotocoagulation; CPT code 66710). Much of the information in this monograph is taken from official publications of the Medicare program. Since economic analyses are a necessary part of any capital budgeting decision, the Corcoran Group incorporated Medicare’s payment rates for TSCPC, as well as recent Medicare utilization rates. FREQUENTLY ASKED QUESTIONS The Corcoran Consulting Group also developed a document with frequently asked questions about reimbursement for MicroPulse® transscleral laser therapy.
ORDERING
To order the MicroPulse P3 Delivery Device, speak with your local sales representative, distributor, email us at customerservice@iridex.com, or call us at +1.650.962.8100 - The part number is 15522
- Six probes are included in a box
- The MicroPulse P3 Device is a single-use device
|
|
|